Recordati SpA (OTCPK:RCDTF)
$ 52.25 0 (0%) Market Cap: 11.25 Bil Enterprise Value: 13.17 Bil PE Ratio: 27.82 PB Ratio: 5.89 GF Score: 92/100

Q4 2021 Recordati Industria Chimica e Farmaceutica SpA Earnings Call Transcript

Feb 24, 2022 / 03:00PM GMT
Release Date Price: $63.96
Operator

This is the chorus call conference operator. Welcome, and thank you for joining the Recordati Conference Call. (Operator Instructions) At this time, I would like to turn the conference over to Ms. Federica De Medici, Investor Relations and Corporate Communications of Recordati. Please go ahead, madam.

Federica De Medici;Robert Koremans
Recordati Industria Chimica e Farmaceutica S.p.A. - Director of IR & Corporate Communications;Recordati Industria Chimica e Farmaceutica S.p.A. - CEO & Director<

Thank you, Sabrina. And good afternoon or good morning to everyone, and thank you for attending the Recordati's conference call today. I'm pleased to be here with our CEO, Robert Koremans; and Luigi La Corte, our CFO that will be presenting the 2021 preliminary full year results and 2022 targets. Then we will be turning you to the presentation. As usual, the set of slides is available on our website under the Investor section. After that, we will open up for Q&A.

I will now leave the floor to Robert. Please go ahead.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot